key: cord-0703119-v4u85129
authors: Leclercq, India; Batéjat, Christophe; Burguière, Ana M; Manuguerra, Jean-Claude
title: Heat inactivation of the Middle East respiratory syndrome coronavirus
date: 2014-06-24
journal: Influenza Other Respir Viruses
DOI: 10.1111/irv.12261
sha: 3ddbaa41fdf3c15e1677fd5cbc0a7d6c7f1e51fc
doc_id: 703119
cord_uid: v4u85129

The culture supernatants of the emerging Middle East respiratory syndrome coronavirus (MERS-CoV) were submitted to three temperatures over time and tested for infectivity by TCID(50) method on Vero E6 cells. At 56°C, almost 25 minutes were necessary to reduce the initial titre by 4 log(10). Increasing temperature to 65°C had a strong negative effect on viral infectivity as virucidy dropped significantly to 1 minute. On the contrary, no significant decrease in titre was observed after 2 hours at 25°C. These data might be useful in establishing biosafety measures in laboratories against MERS-CoV.

The culture supernatants of the emerging Middle East respiratory syndrome coronavirus (MERS-CoV) were submitted to three temperatures over time and tested for infectivity by TCID 50 method on Vero E6 cells. At 56°C, almost 25 minutes were necessary to reduce the initial titre by 4 log 10 . Increasing temperature to 65°C had a strong negative effect on viral infectivity as virucidy dropped significantly to 1 minute. On the contrary, no significant decrease in titre was observed after 2 hours at 25°C. These data might be useful in establishing biosafety measures in laboratories against MERS-CoV.

Keywords Heat, inactivation, MERS-CoV. 

The emerging Middle East respiratory syndrome coronavirus (MERS-CoV) was found to cause sporadic cases of severe acute respiratory infection. Between April 2012 and 26 April 2014, a total of 261 laboratory-confirmed cases of infection with MERS-CoV were reported, including 93 deaths, in nine different countries. 1 To date, the viral transmission route is still not elucidated, although recent studies showed that tomb bats and camels may play a role as reservoirs or intermediate hosts. 2, 3 Coronaviruses are enveloped viruses, usually known to be fragile in the environment. However, enveloped viruses can persist in the environment for extended periods of time, even at 35°C. 4 Understanding the potential effect of heat inactivation of the novel coronavirus is of significant value to elaborate proper public intervention measures.

A human strain of MERS-CoV was isolated in our laboratory from a French patient hospitalised in June 2013 after a nosocomial transmission. 5 The viral strain MERS-CoV Hu/France-FRA2_130569/2013 (FRA2) was grown on MRC5 cells (RD-Biotech REF-84002) for the first passage and on Vero E6 cells (ATCC â CRL-1586) for the second passage. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM 1X, GIBCO; Invitrogen, Saint Aubin, France) and supplemented with 5% foetal calf serum (FCS), antibiotics (0Á1 units penicillin, 0Á1 mg streptomycin per ml, GIBCO; Invitrogen) at 37°C in humidified 5% CO2 incubator. The cell culture supernatant was used for inactivation assays and whole-genome sequencing (manuscript under submission). Culture supernatants (500 ll) with a titre of 10 5Á59 TCID 50 per ml were submitted to three temperatures over time and tested for infectivity by TCID 50 method on Vero E6 cells as described previously, except that examination for cytopathic effect was performed after 6 days. 4 Several time points were chosen (0, 0Á5, 15, 30, 60 and 120 minutes). Each condition was performed in triplicates, and the whole experiment was accomplished twice. Experimental data from one experiment are shown in Table 1 . For each condition, we determined the virucidal activity of heat at 56 and 65°C, which corresponded to a reduction of 4 log 10 of the titre according to the European Standards (NF EN 14476 available at http://www.afnor.org/; Table 2 ). At 56°C, which is the common temperature used for inactivation of enveloped viruses, such as influenza viruses, and serum decomplementation, almost 25 minutes were necessary to reduce the initial titre by 4 log 10 . Increasing temperature to 65°C had a strong negative effect on viral infectivity as virucidy dropped significantly to 1 minute. Fifteen minutes at 65°C is more than sufficient to totally inactivate the sample. By contrast, no decrease in titre was observed after 2 hours at 25°C. Serum heat inactivation at 56°C for 30 minutes is a standard procedure in diagnostic laboratories to eliminate the potential complement interference in serological assays. Our results showed that this procedure is sufficient for viral inactivation as virus titres in blood are expected to be weaker than at the point of infection. This would be also sufficient for inactivation of viruses present in lower respiratory specimens, which are now recommended by WHO rather than nasopharyngeal swabs for viral diagnosis. For example, the FRA2 original clinical specimen (induced sputum) contained 6Á5 9 10 7 genome copies per ml for Orf1a calculated from the C t values using a standard (manuscript under submission). These data might be also useful in establishing biosafety measures in laboratories against MERS-CoV. Slope (a), y-intercept (b) and x-intercept values of the linear regression straight lines calculated from TCID 50 values (ND values in Table 1 were not included in the calculation). Virucidy corresponded to the duration necessary to obtain a fourfold reduction of the titre in log 10 . The values in brackets corresponded to the 99% confidence intervals. NA, not applicable. Each condition was performed in triplicates. The whole experiment was performed twice with similar results (data not shown).

Middle East respiratory syndrome coronavirus (MERS-CoV) -update

Middle East respiratory syndrome oronavirus in Bats, Saudi Arabia

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

Persistence of the 2009 pandemic influenza A (H1N1) virus in water and on non-porous surface

Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

The research leading to these results has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under Grant Agreement N°278433-PREDEMICS. We are also grateful to BNP-Paribas and its foundation (http://www.mecenat.bnpparibas.com/) for their financial support. We also thank Gilberte Coralie, Frederic Fichenick and Claudine Rousseaux for helping.